Yiling Pharmaceutical Co., Ltd. was established on June 16, 1992, and established a unique five-in-one operation mode. It has successively undertaken more than 40 national, provincial and ministerial-level projects such as the National Natural Science Foundation of China and the National Key R&D Program, and more than 10 patented new drugs such as Lianhua Qingwen Capsules for the treatment of colds and anti-influenza. As of December 31, 2020, it has obtained 660 patents It has won more than 30 national, provincial and ministerial science and technology awards, including the first prize of National Science and Technology Progress Award, the second prize of National Science and Technology Progress Award, and the second prize of National Technology Invention Award.
The company has established production bases in many places to ensure product supply, introduced advanced equipment and pharmaceutical technology at home and abroad, and formed three major business sectors of scientific and technological Chinese medicine, biochemical medicine, and health industry, and has continued to grow in the pharmaceutical industry with influence. Top 10 Chinese pharmaceutical companies, top 20 Chinese listed pharmaceutical companies, and top 500 Chinese listed companies by market value.